Bank of Montreal’s Acorda Therapeutics ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-90
| Closed | -$8K | – | 5246 |
|
|
2021
Q1 | $8K | Hold |
90
| – | – | ﹤0.01% | 4487 |
|
|
2020
Q4 | $44K | Buy |
+90
| New | +$8.28K | ﹤0.01% | 4024 |
|
|
2020
Q2 | – | Sell |
-2
| Closed | – | – | 4902 |
|
|
2020
Q1 | $0 | Sell |
2
-49
| -96% | -$9.64K | ﹤0.01% | 4893 |
|
|
2019
Q4 | $13K | Buy |
51
+15
| +42% | +$3.79K | ﹤0.01% | 4503 |
|
|
2019
Q3 | $12K | Hold |
36
| – | – | ﹤0.01% | 4362 |
|
|
2019
Q2 | $33K | Buy |
36
+13
| +57% | +$16K | ﹤0.01% | 3895 |
|
|
2019
Q1 | $36K | Buy |
23
+5
| +28% | +$9.01K | ﹤0.01% | 3473 |
|
|
2018
Q4 | $34K | Buy |
18
+9
| +100% | +$19.6K | ﹤0.01% | 3442 |
|
|
2018
Q3 | $21K | Hold |
9
| – | – | ﹤0.01% | 3698 |
|
|
2018
Q2 | $31K | Buy |
9
+3
| +50% | +$9.19K | ﹤0.01% | 3601 |
|
|
2018
Q1 | $18K | Hold |
6
| – | – | ﹤0.01% | 3589 |
|
|
2017
Q4 | $17K | Sell |
6
-93
| -94% | -$264K | ﹤0.01% | 3642 |
|
|
2017
Q3 | $280K | Sell |
99
-416
| -81% | -$1.1M | ﹤0.01% | 2519 |
|
|
2017
Q2 | $1.22M | Sell |
515
-678
| -57% | -$1.34M | ﹤0.01% | 1895 |
|
|
2017
Q1 | $3.01M | Sell |
1,193
-4
| -0.3% | -$11.5K | ﹤0.01% | 1305 |
|
|
2016
Q4 | $2.99M | Buy |
1,197
+637
| +114% | +$1.51M | ﹤0.01% | 1329 |
|
|
2016
Q3 | $1.4M | Sell |
560
-43
| -7% | -$128K | ﹤0.01% | 1669 |
|
|
2016
Q2 | $1.85M | Buy |
603
+537
| +814% | +$1.75M | ﹤0.01% | 1547 |
|
|
2016
Q1 | $211K | Sell |
66
-41
| -38% | -$170K | ﹤0.01% | 2432 |
|
|
2015
Q4 | $550K | Sell |
107
-9
| -8% | -$39.3K | ﹤0.01% | 1952 |
|
|
2015
Q3 | $370K | Sell |
116
-19
| -14% | -$73.7K | ﹤0.01% | 1993 |
|
|
2015
Q2 | $538K | Buy |
135
+5
| +4% | +$19.3K | ﹤0.01% | 1932 |
|
|
2015
Q1 | $518K | Buy |
130
+118
| +983% | +$540K | ﹤0.01% | 1913 |
|
|
2014
Q4 | $59K | Buy |
12
+4
| +50% | +$17.2K | ﹤0.01% | 2999 |
|
|
2014
Q3 | $32K | Sell |
8
-76
| -90% | -$285K | ﹤0.01% | 3299 |
|
|
2014
Q2 | $341K | Sell |
84
-1
| -1% | -$4.08K | ﹤0.01% | 2276 |
|
|
2014
Q1 | $387K | Sell |
85
-1
| -1% | -$4.04K | ﹤0.01% | 2188 |
|
|
2013
Q4 | $300K | Buy |
86
+15
| +21% | +$58.5K | ﹤0.01% | 2059 |
|
|
2013
Q3 | $292K | Sell |
71
-26
| -27% | -$112K | ﹤0.01% | 2067 |
|
|
2013
Q2 | $383K | Buy |
+97
| New | +$399K | ﹤0.01% | 1875 |
|
Other funds holding ACOR
CCA
BCM
Bank of Montreal's ACOR Position: Q2 2021 in Review
Bank of Montreal sold out of Acorda Therapeutics (ACOR) in Q2 2021, closing a stake of 90 shares — an estimated $8K sold.
Bank of Montreal first reported a position in ACOR in Q2 2013 and held it in 30 quarters. The position peaked at $3.01M in Q1 2017. 34 funds tracked by Wall St. Rank hold ACOR as of Q2 2021.
- Bank of Montreal reported no remaining Acorda Therapeutics position as of Q2 2021 after selling out during the quarter.
- Bank of Montreal sold 90 Acorda Therapeutics shares in Q2 2021, an estimated $8K.
- Bank of Montreal first reported a position in Acorda Therapeutics in Q2 2013 and held it in 30 quarters.
- Bank of Montreal's Acorda Therapeutics position peaked at $3.01M in Q1 2017.
- 34 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2021.
Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.